CN109730952B - Water extraction process of lava seawater containing dendrobium officinale - Google Patents
Water extraction process of lava seawater containing dendrobium officinale Download PDFInfo
- Publication number
- CN109730952B CN109730952B CN201910008542.6A CN201910008542A CN109730952B CN 109730952 B CN109730952 B CN 109730952B CN 201910008542 A CN201910008542 A CN 201910008542A CN 109730952 B CN109730952 B CN 109730952B
- Authority
- CN
- China
- Prior art keywords
- dendrobium officinale
- lava seawater
- skin
- extract
- lava
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001076416 Dendrobium tosaense Species 0.000 title claims abstract description 46
- 239000013535 sea water Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title description 9
- 230000008569 process Effects 0.000 title description 4
- 238000003809 water extraction Methods 0.000 title description 2
- 239000000284 extract Substances 0.000 claims abstract description 39
- 239000002904 solvent Substances 0.000 claims abstract description 14
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 5
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- 239000004744 fabric Substances 0.000 claims abstract description 4
- 239000011550 stock solution Substances 0.000 claims abstract description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 2
- 230000003020 moisturizing effect Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 10
- 230000002401 inhibitory effect Effects 0.000 abstract description 9
- 230000002087 whitening effect Effects 0.000 abstract description 5
- 230000037303 wrinkles Effects 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 42
- 210000004027 cell Anatomy 0.000 description 28
- 230000000052 comparative effect Effects 0.000 description 28
- 210000003491 skin Anatomy 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 210000002950 fibroblast Anatomy 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 11
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 10
- 239000012888 bovine serum Substances 0.000 description 10
- 102000008186 Collagen Human genes 0.000 description 9
- 108010035532 Collagen Proteins 0.000 description 9
- 229920001436 collagen Polymers 0.000 description 9
- 230000002068 genetic effect Effects 0.000 description 9
- 210000002510 keratinocyte Anatomy 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 201000001441 melanoma Diseases 0.000 description 9
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 210000002752 melanocyte Anatomy 0.000 description 7
- 108090000991 Aquaporin 3 Proteins 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 6
- 230000003013 cytotoxicity Effects 0.000 description 6
- 210000002615 epidermis Anatomy 0.000 description 6
- 102100037332 Aquaporin-3 Human genes 0.000 description 5
- 102000012422 Collagen Type I Human genes 0.000 description 5
- 108010022452 Collagen Type I Proteins 0.000 description 5
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229940096422 collagen type i Drugs 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 238000003753 real-time PCR Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000006286 aqueous extract Substances 0.000 description 4
- 238000010804 cDNA synthesis Methods 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 230000003061 melanogenesis Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000037394 skin elasticity Effects 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 238000010818 SYBR green PCR Master Mix Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000003149 assay kit Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000036252 glycation Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical class N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002096 quantum dot Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 231100000820 toxicity test Toxicity 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 231100000002 MTT assay Toxicity 0.000 description 2
- 238000000134 MTT assay Methods 0.000 description 2
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 2
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000010805 cDNA synthesis kit Methods 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- IGGVVGHJSQSLFO-UHFFFAOYSA-N indole-5,6-quinone Chemical compound O=C1C(=O)C=C2C=CNC2=C1 IGGVVGHJSQSLFO-UHFFFAOYSA-N 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 230000003405 preventing effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 1
- IWHLQVYDCVARSF-UHFFFAOYSA-N 5,6-dihydro-1h-indole Chemical compound C1CC=C2NC=CC2=C1 IWHLQVYDCVARSF-UHFFFAOYSA-N 0.000 description 1
- RYPSAGYJJZPDQN-UHFFFAOYSA-N 5,6-dihydro-1h-indole-2-carboxylic acid Chemical compound C1CC=C2NC(C(=O)O)=CC2=C1 RYPSAGYJJZPDQN-UHFFFAOYSA-N 0.000 description 1
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000026010 Dendrobium candidum Species 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
- 101710093778 L-dopachrome tautomerase Proteins 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007256 Nevus Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 1
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- -1 dihydroxyindole 5, 6-dihydroindole Chemical compound 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- MKYNHKOAYQRSBD-UHFFFAOYSA-N dioxouranium;nitric acid Chemical compound O=[U]=O.O[N+]([O-])=O.O[N+]([O-])=O MKYNHKOAYQRSBD-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000006525 intracellular process Effects 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a lava seawater extraction process containing dendrobium officinale, which adopts lava seawater as an extract stock solution, and the lava seawater is sterilized by a sterilizing filter; adding Dendrobium officinale stems into the lava seawater, reflux-extracting, filtering with filter cloth, and filtering with filter to completely remove solvent to obtain the powder of the extract of Dendrobium officinale from lava seawater. The invention adopts the lava seawater dendrobium officinale extract as the effective component, and has the effects of improving wrinkles, inhibiting saccharification, whitening and moisturizing the skin.
Description
Technical Field
The invention relates to a lava seawater extraction process for dendrobium officinale.
Background
The skin in the human body is a body organ which is most closely contacted with the external environment, has the function of protecting the interior of the human body, and can be divided into epidermis, dermis and subcutaneous fat. The skin is a complex organ composed of cells with various functions and substances adapted to the cells, wherein the dermis layer is a combination of elastic solid substances (fibers) and viscous liquid substances, and can maintain the inherent elasticity of the skin. The skin therefore responds to tension with unique physical properties, which we call viscoelastic. The skin has such viscoelasticity because proteoglycan includes collagen fibers and elastic fibers, which constitute a unique three-dimensional component. Generally, the skin function is decreased and the skin becomes atrophic due to aging, ultraviolet rays, pollution, stress, and the like, and the number of skin cells is decreased or the thickness of the skin is reduced. For these reasons, the elastic fibers of the skin deform to cause a reduction in the elasticity of the skin or a relaxation of the skin.
Collagen is a main component constituting the skin, and type II collagen accounts for 80% and type III collagen accounts for 15%. Under the long-term exposure to ultraviolet rays, active nutrients in the skin are generated in large amounts, resulting in the promotion of the expression or activity of the collagen-degrading enzyme MMP-1 in the matrix metalloproteinases MMPs, resulting in the reduction of collagen synthesis and thus in the reduction of skin elasticity. Therefore, in order to treat skin and prevent skin aging, we have developed a novel material having the efficacy of expressing MMP-1, inhibiting its activity, and promoting collagen synthesis, which can be a good strategy.
Also, collagen and elastin are susceptible to chemical reactions within the body known as glycation. This is a non-enzymatic reaction that results from the combination of free amino groups containing proteins and reducing sugars, such as glucose. Glucose, which powers cells, may react with proteins such as collagen. This will result in the Advanced Glycation End-products (AGEs) and Reactive Oxygen Species (ROS). One of the AGEs, carboxymethylethylysine (cml), in particular, causes changes in skin elasticity during UV-induced photoaging, gives the skin elasticity and collagen to accumulate AGEs, which negatively affects cross-linking of protein fibers, loss of elasticity, intra-dermal changes, etc.
AGEs generated in the skin act on the receiver site to generate AGE (RAGE) complex. RAGE signaling conveys inflammatory and sequelae-related intracellular processes. These are important as they are the main causes of the inflammatory aging process and the catalytic action of many diseases. For example, diabetic patients have a high glycemic index in their blood and develop complications such as cataract and arteriosclerosis accompanied by the formation of AGEs in their bodies. For these reasons, diabetes is considered to be a disease in which aging is accelerated due to increased inflammation caused by the production of AGEs. This is not limited to diabetes. Physical weakness, heart disease and many brain related diseases are associated with glycation. Scientists believe that reducing glycation means slowing the aging process and disease induction. The generation of AGEs is a mechanism that determines how old the skin is and how the disease is generated in our body, and is a field of most attention.
Pigmentation of skin such as black nevi and freckles is caused by an increase in melanin in the epidermis, and melanin is also an important factor determining skin color. Melanin is produced in pigment granule organs within melanocytes of the basal layer of the epidermis. That is, the mitosis of melanocytes occurs due to ultraviolet rays, and then melanocytes are activated. The synthesis of tyrosinase and tyrosinase is promoted in activated melanocytes, and the production of melanin is enhanced to transport and discharge the melanin to the outside of epidermis.
Naturally occurring melanin is a mixture of alkali-insoluble black melanin (neomelanin) and alkali-soluble yellow to red melanin (pheomelanin). The melanin polymers in general are mostly referred to as neomelanin. In contrast, according to the studies of Prota (g. Prota., j. invest. dermotol., 75, p122, 1980.) and Pavel (s. Pavel et al, Cancer Detection and preservation, 6, p311., 1983.), the new melanin includes not only the dihydroxyindole 5, 6-dihydroindole which we have thought, but also other melanin monomers (5, 6-dihydroindole-2-Carboxylic acid) and melanin produced from various melanin intermediate metabolites. The melanogenesis process in melanosomes is tyrosine oxidation by the enzyme tyrosinase (DOPA) → (dopaquinone) → (5, 6-dihydroindole) → (indole-5,6-quinone), followed by the production of melanin due to the polymerization of (indole-5, 6-quinone). Wherein tyrosinase is intervening until the tyrosine step, and the possibility that several subsequent steps are autoxidized is high. The phenomenon of pigmentation, i.e., blackening, which occurs in sunbathing or the like is caused by an increase in melanin formation due to ultraviolet rays in sunlight.
The processes of melanogenesis and the mechanisms of action for inhibiting melanogenesis in melanocytes, which have been known so far, are roughly classified into two types. The first is to inhibit the production of melanin by cytotoxic action on melanocytes, and the second is to inhibit the production of melanin in melanocytes, thereby inhibiting the production of melanin. According to the recently published papers, not only tyrosinase but also TRP-1 and TRP-2 produce melanin, which is an important enzyme for the intervention of melanin biosynthesis, and if substances capable of inhibiting the production of these enzymes are developed, it is a good method for preventing skin pigmentation.
The human body is mostly composed of water, which is an important component for maintaining a living body. Normal skin contains 70% of water in the body, and the stratum corneum contains 20% to support the elasticity and softness of the skin. When the water content of the horny layer is 10% or less, dry skin is commonly called a cause of skin troubles. The moisture balance of the skin is regulated according to the epidermis. Although the stratum corneum of the epidermis is formed by the accumulation of dead cells, it plays a very important role in maintaining water in the skin. The water content in the horny layer due to regular keratinization is maintained at 10 to 20%. This is a sebum membrane formed by mixing sweat and sebum, and protects the skin from the outside and prevents the evaporation of water from the stratum corneum. The natural moisturizing factor and the dermal lipid capture and maintain moisture. The dermal lipid membrane NMF and dermal lipids act together to maintain moisture. NMF is produced during keratinization, is a hydrophilic, hygroscopic substance, and plays a very important role in skin moisturization. It is composed of amino acids and can lock the moisture of stratum corneum. Also PCA in NMF is of particular importance. As a matrix filling between the respective cells, the layer is formed so as to maintain the moisture inside.
It is reported that the decrease in the amount of hyaluronic acid in human skin with aging is considered to be one of the direct causes of the decrease in skin elasticity and the decrease in moisture content with aging.
Disclosure of Invention
In order to solve the technical problems, the invention provides a lava seawater extraction process containing dendrobium officinale, lava seawater is used as an extract stock solution, and the lava seawater is sterilized by a sterilization filter; adding Dendrobium officinale stems into the lava seawater, reflux-extracting, filtering with filter cloth, and filtering with filter to completely remove solvent to obtain the powder of the extract of Dendrobium officinale from lava seawater.
Further, the cosmetic composition further comprises AQP-3 or HAS-2.
Further, 0.01-10 wt% of the lava seawater dendrobium officinale extract is added based on 100 wt% of the whole.
The invention adopts the lava seawater dendrobium officinale extract as the effective component, and has the effects of improving wrinkles, inhibiting saccharification, whitening and moisturizing the skin.
Drawings
FIG. 1 shows the cytotoxicity results of Fibroplast in example 1 and comparative example 1 on fibroblasts.
FIG. 2 shows the cytotoxicity results of example 1 and comparative example 1 on keratinocytes HaCaT.
FIG. 3 shows the results of comparison of the expression of the Collagen type 1 gene in fibroblasts of example 1 and comparative example 1.
FIG. 4 shows the results of comparing RAGE genetic gene expression of example 1 and comparative example 1 in fibroblasts.
FIG. 5 shows the results of comparing the expression of AQP-3 genes of example 1 and comparative example 1 in keratinocytes.
FIG. 6 shows the results of comparing the expression of HAS-2 gene in keratinocytes in example 1 and comparative example 1.
FIG. 7 shows cytotoxicity results for melanoma (B16-F1) in example 1 and comparative example 1.
FIG. 8 shows the results of comparison of the melanin production per cell in melanoma (B16-F1) in example 1 and comparative example 1.
Detailed Description
Production example 1: water intake of lava seawater
In east China, county, old Leyi-Han, 150m underground, the lava seawater collected at 44.35m of the average surface of the underground sea (sea level as reference) was sterilized by a sterilizing filter. The thus sterilized lava seawater (in a state of not desalted brine) is used for the subsequent production of the dendrobium officinale lava seawater extract. The mineral composition of the sterilized lava seawater is as shown in table 1 below.
[ TABLE 1 ]
Example 1: preparation method of water extract of Dendrobium officinale Kimura et Migo from lava sea
Taking 1kg of dendrobium officinale stem, adding 20 kg of lava seawater, extracting at 90 ℃ under reflux for 3 hours, filtering with 250-mesh filter cloth, and then filtering with a 1 ㎛ filter. The filtrate was completely freed of solvent by a vacuum concentrator (EYELA 사, N-1000, Japan) to obtain 226 g of extract powder of Dendrobium officinale and lava seawater.
The extract of dendrobium candidum in lava seawater is added in an amount of 0.01-10 wt% based on 100 wt% of the whole body, so that the extract has good effects of improving skin wrinkles and inhibiting saccharification, and has whitening and moisturizing effects.
Comparative example 1: preparation of pure water extract of Dendrobium officinale
The extract was prepared from Dendrobium officinale stems under the same conditions as in example 1, i.e., pure water was used instead of lava seawater. 29g of dendrobium officinale pure water extract powder is obtained.
And (3) comparison: cytotoxicity measurements with fibroblasts (fibroplasts) and keratinocytes (HaCaT)
To measure the anti-wrinkle effect, anti-glycation effect, whitening effect and moisturizing effect of the dendrobium officinale kimura sea water extract of example 1 and the dendrobium officinale pure water extract of comparative example 1, toxicity test was performed by MTT assay in human Fibroblast and keratinocyte HaCaT. MTT assay is used for detecting the number of living cells and is generally used for thin cellA method for detecting cell proliferation or cytotoxicity. The living cells are water soluble in mitochondria and the assay utilizes the yellow salt MTT (3- [4, 5-dimethylthiozole-2-yl)]-2, 5-diphenyltetrazolium bromide) is reduced to a water-insoluble blue formazan derivative by succinate dehydrogenase (or mitogenic dehydrogenase). Fibroblast Fibrolast and keratinocyte HaCaT cell were seeded on the bottom of a culture dish, and then cultured in medium containing 5% carbon dioxide at 37 ℃ in IMDM (using Iscove's modified Dulbecco's medium-Fibrolast cell, or DMEM (using Dulbecco's modified Eagle's medium-HaCaT cell) containing penicillin 100U/㎖, streptomycin 100 ㎍/㎖, 10% bovine serum (FBS), human Fibroblast cell and keratinocyte HaCaT cell were cultured in 24-well cell culture plates at 1X 25 105cells/ml, 1.5x105cells/ml were diluted and inoculated with 1 ㎖ cells, respectively, and cultured for 24 hours. After the culture, the culture medium was completely removed, and the culture medium containing no bovine serum was placed, and the extracts of example 1 and comparative example 1 were treated at the concentrations. After culturing at 37 ℃ for 24 hours in a medium containing 5% carbon dioxide, the whole culture medium was purged and replaced with a 10-fold diluted culture medium of 2.5mg/㎖ MTT solution, and the culture medium was cultured for 4 hours. After 4 hours, the supernatant was removed, a DMSO solution as a solvent for dissolving 1 ㎖ was added, and the absorbance of the resulting crystals at 570nm of MTT formazan was measured. In this case, the control group used a dissolution solvent, DMSO. Please refer to table 1 and table 2 for toxicity test results.
[ TABLE 1 ]
[ TABLE 2 ]
The water extract of Dendrobium officinale Kimura et Migo of example 1 and the pure water extract of Dendrobium officinale Kimura et Migo of comparative example 1 both showed no toxicity at concentrations below 1000 ㎍/㎖.
Experimental example 2: investigation of amount of expression of Collagen type I mRNA
To measure the Collagen synthesis-promoting effects of the sea water extract of Dendrobium officinale Kimura et Migo of example 1 and the pure water extract of Dendrobium officinale Kimura et Migo of comparative example 1, Collagen type I genetic gene expression experiments were performed on samples processed on commercially purchased human fibroblasts. Human Fibroblast Fibroplasts purchased at ATCC (American Type Culture Collection) at 1X10 together with IMDM (Iscove's Modified Dulbecco's Media) Culture broth containing 10% bovine serum in 60mm dish6cells/well concentration aliquot at 37 ℃ 5% CO2 Incubated under conditions for 24 hours. After 24 hours, the sample was diluted with an IMDM culture medium containing no bovine serum at a certain concentration for 24 hours, and the cells were collected in TRIzol (invitrogen, USA) to isolate RNA. The isolated RNA was used with a QubitAfter quantification of fluoroemeter with RNA BR Assay kit, the gene was amplified using Real-Time PCR 7500 Fast with Power SYBR Green PCR master mix (Applied Biosystems, USA), and the product was quantitatively analyzed. Using Collagen type I and β -Actin primer (Korea) in PCR, primer sequence please refer to Table 3. The control group used solvent-treated DMSO (dimethyl sulfoxide), and the positive control group used well-known antioxidant Vitamin C. See table 4, fig. 3 for experimental results.
[ TABLE 3 ]
[ TABLE 4 ]
The aqueous extract of Dendrobium officinale Kimura et Migo of example 1 and the pure aqueous extract of Dendrobium officinale Kimura et Migo of comparative example 1 confirmed the expression of the Collagen type I genetic gene. Experimental example 1A larger amount of Collagen type I than the control group was expressed, and it was confirmed that it had an anti-wrinkle effect. It was confirmed that the wrinkle preventing effect was more excellent in example 1 than in comparative example 1.
EXAMPLE 3 investigation of expression amount of RAGE mRNA
To examine the anti-glycation effects of the sea water extract of Dendrobium officinale Kimura et Migo of example 1 and the pure water extract of Dendrobium officinale Kimura et Migo of comparative example 1, RAGE genetic gene expression experiments were performed on samples processed on commercially purchased human fibroblasts. Human fibroblasts (fibroplast) were cultured at 1X10 in 60mm dish together with IMDM (Iscove's Modified Dulbesco's Media) medium containing 10% bovine serum6Cell/dish concentration aliquots at 37 ℃ with 5% CO2Incubated under conditions for 24 hours. After 24 hours, the culture medium was removed, HBSS (Hank's Balanced salt solution) 3 ㎖ was added, and UVA 6J/cm was performed2After the treatment, the sample was diluted in a bovine serum-free IMDM culture medium for 48 hours at a certain concentration, and the cells were collected in TRIzol (invitrogen, USA) to isolate RNA. The isolated RNA was used with a QubitAfter quantitative determination of fluorometer with RNA BR Assay kit, cDNA (complementary DNA) was synthesized and subjected to Real-time PCR. cDNA Synthesis Using a cDNA Synthesis Kit (High Capacity RNA to cDNA Kit, Applied Biosystems, USA), experiments were performed according to the method of Kit. The gene was amplified using a Real-Time PCR 7500 Fast with Power SYBR Green PCR master mix (Applied Biosystems, USA) and the product was quantitatively analyzed. RAGE and beta-Actin primer (Korea) used in PCR, primer sequence please refer [ Table 5]. The control group used solvent-treated DMSO (dimethyl sulfoxide), and the UVA-treated group used UVA 6J/cm2And solvent-treated dmso (dimethylsulfoxide). The positive control group used the well known antioxidant Resveratrol. See table 6 and fig. 4 for experimental results.
[ TABLE 5 ]
[ TABLE 6 ]
The aqueous extract of the Dendrobium officinale Kimura et Migo sea of example 1 and the pure aqueous extract of Dendrobium officinale Kimura et Migo of comparative example 1 determined the expression of RAGE genetic genes. Both example 1 and comparative example 1 had a significant inhibitory effect on UVA-induced increased RAGE genetic gene expression. It was confirmed that the wrinkle-preventing effect was more excellent in example 1 than in comparative example 1.
Experimental example 4: AQP-3, HAS-2 mRNA expression survey
To measure the moisturizing effects of the dendrobium officinale kimura sea water extract of example 1 and the dendrobium officinale pure water extract of comparative example 1, samples were treated on human keratinocytes to perform experiments. Keratinocyte HaCaT was cultured in 60mm dish in 1.5X10 DMEM (Dulbecco's modified Eagle's medium) containing 10% bovine serum6Cell/dish concentration aliquots at 37 ℃ with 5% CO2Incubated under conditions for 24 hours. After 24 hours, the sample was diluted at a certain concentration in a DMEM culture solution containing no bovine serum for 24 hours, and the cells were collected in TRIzol (invitrogen, USA) to isolate RNA. The isolated RNA was used with a QubitAfter quantitative determination of fluorometer with RNA BR Assay kit, cDNA (complementary DNA) was synthesized and Real-time PCR was performed. cDNA Synthesis Using a cDNA Synthesis Kit (High Capacity RNA to cDNA Kit, Applied Biosystems, USA), experiments were performed according to the method of Kit. After amplification of the genetic gene using the Real-Time PCR 7500 Fast with Power SYBR Green PCR master mix (Applied Biosystems, USA), the increased product was quantitatively analyzed. AQP-3, HAS-2 and beta-Actin primer (Korea) used in PCR, primer sequence please refer to [ Table 7 ]]. The control group used solvent-treated DMSO (dimethyl sulfoxide), and the positive control group used Retinoic acid with moisturizing effect. Fruit of Chinese wolfberrySee table 8, table 9, fig. 5, and fig. 6 for experimental results.
[ TABLE 7 ]
[ TABLE 8 ]
The expression of AQP-3 genetic genes of the dendrobium officinale kimura sea water extract of example 1 and the dendrobium officinale pure water extract of comparative example 1 was confirmed. It was demonstrated that AQP-3 was expressed in a larger amount than the control group in Experimental example 1, and it was confirmed that it had a moisturizing effect. It was also confirmed that example 1 has a better moisturizing effect than comparative example 1.
[ TABLE 9 ]
The expression of the HAS-2 genetic genes of the dendrobium officinale lava sea water extract of example 1 and the dendrobium officinale pure water extract of comparative example 1 was confirmed. It was shown that experimental example 1 and comparative example 1 expressed a larger amount of HAS-2 than the control group, and it was confirmed that the moisturizing effect was exhibited. It was also confirmed that example 1 has a better moisturizing effect than comparative example 1.
Experimental example 8: detection of cytotoxicity Using melanoma cells (B16-F1)
To measure the toxicity of the water extracts of Dendrobium officinale Kimura et Migo of example 1 and the purified water extract of Dendrobium officinale Kimura et Migo of comparative example 1, samples were treated on commercially available melanoma (B16-F1) cells for experiments. Melanoma (B16-F1) cells were plated at 1X10 in 6 well plates in DMEM (Dulbecco's modified Eagle's medium) with 10% bovine serum5Cell/well concentration aliquot at 37 ℃ 5% CO2 Incubated under conditions for 24 hours. After 24 hours, the sample was placed in a medium containing alpha-Melanocyte stimulane hormone (alpha-MSH) and 10% bovine serumThe cells were cultured in fresh DMEM at a diluted concentration for 72 hours. After 72 hours of culture, all the culture medium was removed, and the culture medium was cultured for 4 hours while alternating 10-fold dilution with MTT solution at 2.5mg/㎖. After 4 hours, the supernatant was removed, and 2 ㎖ DMSO (dimethyl sulfoxide) solution was added to detect the absorbance of the MTT formazan crystals at 570 nm. The non-treated group used solvent-treated DMSO (dimethyl sulfoxide), and the alpha-MSH-treated group used alpha-MSH and solvent-treated DMSO (dimethyl sulfoxide). Arbutin (SK Bioland) was used as the positive control group, and the toxicity test results are shown in Table 10 and FIG. 7.
[ TABLE 10 ]
The water extract of Dendrobium officinale Kimura et Migo of example 1 and the pure water extract of Dendrobium officinale Kimura et Migo of comparative example 1 both showed no toxicity at concentrations below 50 ㎍/㎖.
Experimental example 9: melanoma (B16-F1) cell detection for melanin biosynthesis inhibition effect
To measure the whitening effects of the water extracts of Dendrobium officinale Kimura et Migo of example 1 and the purified water extract of Dendrobium officinale Kimura et Migo of comparative example 1, samples were treated on commercially available melanoma B16-F1 cells for experiments. The melanogenesis inhibitory effect of melanoma cells was examined by the method (Fukuda et al, j. soc. Cosmetic chem., 42(361), 1991) and its modification. Melanoma B16-F1 cells were plated at 1X10 in 6 well plates in DMEM (Dulbecco's modified Eagle's medium) with 10% bovine serum5Cell/well concentration aliquot at 37 ℃ 5% CO2 Incubated under conditions for 24 hours. After 24 hours, the samples were diluted and cultured in α -Melanocyte potentiate hormon (α -MSH) and fresh DMEM containing 10% bovine serum at the given concentrations for 72 hours. After 72 hours of culture, all the cells from which the culture medium had been removed were washed with PBS (saline) 2 ㎖, treated with 1N NaOH 0.5 ㎖, and the cells were recovered with 1.5 ㎖ tube to obtain melanin in the cells. Will come back toThe collected cells move to a 96 well plate, and the absorbance is detected at 450nm to obtain a certain amount of protein carbohydrate melanin. The non-treated group used solvent-treated DMSO (dimethyl sulfoxide), and the alpha-MSH-treated group used alpha-MSH and solvent-treated DMSO (dimethyl sulfoxide). Arbutin (SK Bioland) was used as the positive control group. See table 11 and fig. 8 for the results of the melanin biosynthesis inhibition assay.
[ TABLE 11 ]
Claims (1)
1. The preparation method of the dendrobium officinale lava sea water extract is characterized by comprising the following steps: adopting lava seawater as an extract stock solution, and sterilizing the lava seawater by using a sterilizing filter; adding Dendrobium officinale stems into the lava seawater, reflux-extracting, filtering with filter cloth, filtering with a filter, and completely removing solvent from the filtrate with a vacuum concentrator to obtain the powder of the lava seawater extract of Dendrobium officinale.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910008542.6A CN109730952B (en) | 2019-01-04 | 2019-01-04 | Water extraction process of lava seawater containing dendrobium officinale |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910008542.6A CN109730952B (en) | 2019-01-04 | 2019-01-04 | Water extraction process of lava seawater containing dendrobium officinale |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109730952A CN109730952A (en) | 2019-05-10 |
CN109730952B true CN109730952B (en) | 2021-09-10 |
Family
ID=66363481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910008542.6A Active CN109730952B (en) | 2019-01-04 | 2019-01-04 | Water extraction process of lava seawater containing dendrobium officinale |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109730952B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106692692A (en) * | 2015-08-21 | 2017-05-24 | 中国科学院昆明植物研究所 | Dendrobium officinale extract and preparation method thereof |
KR20170059651A (en) * | 2015-11-23 | 2017-05-31 | 대봉엘에스 주식회사 | Method of preparing green tea extract by using magma seawater, carbonated water, or bedrock water, and functional cosmetic composition comprising the same |
WO2017222304A1 (en) * | 2016-06-24 | 2017-12-28 | 코스맥스 주식회사 | Lava sea salt with reduced cytotoxicity and method for producing same |
WO2018062733A1 (en) * | 2016-09-30 | 2018-04-05 | 주식회사 아모레퍼시픽 | Composition comprising green tea extract for improving blood glucose control, prepared using desalted lava seawater |
CN108464960A (en) * | 2018-04-17 | 2018-08-31 | 凯瑞欧(天津)生物技术有限公司 | A kind of dendrobium candidum beauty-care gel |
-
2019
- 2019-01-04 CN CN201910008542.6A patent/CN109730952B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106692692A (en) * | 2015-08-21 | 2017-05-24 | 中国科学院昆明植物研究所 | Dendrobium officinale extract and preparation method thereof |
KR20170059651A (en) * | 2015-11-23 | 2017-05-31 | 대봉엘에스 주식회사 | Method of preparing green tea extract by using magma seawater, carbonated water, or bedrock water, and functional cosmetic composition comprising the same |
WO2017222304A1 (en) * | 2016-06-24 | 2017-12-28 | 코스맥스 주식회사 | Lava sea salt with reduced cytotoxicity and method for producing same |
WO2018062733A1 (en) * | 2016-09-30 | 2018-04-05 | 주식회사 아모레퍼시픽 | Composition comprising green tea extract for improving blood glucose control, prepared using desalted lava seawater |
CN108464960A (en) * | 2018-04-17 | 2018-08-31 | 凯瑞欧(天津)生物技术有限公司 | A kind of dendrobium candidum beauty-care gel |
Also Published As
Publication number | Publication date |
---|---|
CN109730952A (en) | 2019-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110731919B (en) | Application of mirabilis jalapa extract and skin external preparation containing mirabilis jalapa extract | |
KR101774414B1 (en) | Composition for improving skin condition comprising exopolysaccharide produced by ceriporia lacerata as an active ingredient | |
CN107375048B (en) | Whitening composition and application thereof | |
CN111944870B (en) | Phyllanthus emblica extract fermentation product and preparation and application thereof | |
KR20110047824A (en) | Cosmetic Composition Comprising Citron Extracts | |
WO2013102727A1 (en) | Extract of kniphofia uvaria seeds, cosmetic or dermatological composition containing same, and uses thereof | |
US20120100086A1 (en) | Bleaching peptide hydrolyzate proteasome activator and compositions containing same | |
CN109730952B (en) | Water extraction process of lava seawater containing dendrobium officinale | |
US20230210757A1 (en) | Improvements in or relating to organic compounds | |
CN112546105B (en) | Application of rose extract in preparing anti-aging and anti-oxidation composition | |
KR102211942B1 (en) | Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry | |
FR2946878A1 (en) | Use of floridoside or an extract of red algae containing floridoside for the manufacture of a cosmetic active ingredient that inhibits melanogenesis in a cosmetic composition | |
Ha et al. | Anti-skin aging potential of alcoholic extract of Phragmites communis rhizome | |
WO2020015726A1 (en) | Use of nitraria tangutorum bobr. extracts and skin external preparations comprising the same | |
KR101816532B1 (en) | Detoxified lava seawater salt and and manufacturing method thereof | |
KR102420544B1 (en) | Composition for preventing the skin aging comprising rosa gallica petal extracts as an active ingredient | |
KR20140089305A (en) | Composition for improving skin whitening or skin wrinkle comprising extracts of Quercus salicina Blume | |
KR20160128719A (en) | The cosmetic composition has a whitening effect of the active ingredients of physiologically algae | |
EP2590622B1 (en) | Use of populus balsamifera extract as depigmenting agent | |
KR20190025329A (en) | A cosmetic composition comprising salix gracilistyla extract | |
KR102667190B1 (en) | Compostions for Skin Whitening and Skin Wrinkle Improvement Using Fucoidan Extracted from Sargassum horneri | |
KR102652692B1 (en) | A cosmetic compositon comprising antarctic microorganism | |
KR102657397B1 (en) | Multifunctional cosmetic composition containing multi-molecular collagen and Kakadu plum extract | |
WO2019174786A1 (en) | Use of an ilex aquifolium extract for treating skin pigmentation disorders and for skin whitening | |
KR102201415B1 (en) | Extraction method of grape extract and manufacturing method of cosmetics composition comprising said extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 226100 1 Tianmu Lake Road, Linjiang new area, Haimen, Nantong, Jiangsu Applicant after: HYUNDAI BIOLAND(Jiangsu) Co.,Ltd. Applicant after: BOTANIERA (HANGZHOU) HEALTH TECHNOLOGY CO.,LTD. Address before: 226100 1 Tianmu Lake Road, Linjiang new area, Haimen, Nantong, Jiangsu Applicant before: SK BIOLAND BIOTECHNOLOGY (HAIMEN) Co.,Ltd. Applicant before: BOTANIERA (HANGZHOU) HEALTH TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |